This is an up-to-date and comprehensive CLL guide, including the latest therapeutic and diagnostic developments, delivered by UK CLL Forum members. This training course is intended to provide Healthcare Professionals with a grounding in the latest in the identification, progression and treatment of Chronic Lymphocytic Leukaemia (CLL).

TOPICS COVERED

The course, which consists of two half days of learning, is free to access and will contribute to your continual professional development objectives. There will be total of six presentation over 2 days, following each 40 mins of presentation there will be 20 mins discussion with the chair, speaker and other 3 panel members all the learning points raised and stressing the patient perspective.

You may at the time of signing up make a donation towards CLL Support Association. This is voluntary, but appreciated as it helps us to continue our efforts in improving services to patients in this important area. It will be delivered virtually. You will have the option to donate when you book your ticket.

WHO SHOULD ATTEND?

It is aimed primarily at consultants, CNS, ANPs and Trainee Haematologists, for anyone who will encounter CLL patients.

SPEAKERS

2 July 2022 Saturday, chair Prof G Follows, Consultant Haematologist, Visiting Professor of Haematology, Anglia Ruskin Medical School, Associate Lecturer, University of Cambridge.

• CLL – natural history / presentation / W&W / complications related to CLL not therapy, Dr Rosalynd Johnston, Consultant Haematologist, University Hospitals Sussex, Royal Sussex County Hospital.
• CLL – laboratory work up and prognostic biology, Dr Ben Kennedy, Consultant Haematologist and Honorary Associate Professor, Department of Haematology, Leicester Royal Infirmary.
• CLL first line therapy – choices and considerations, Dr Piers Patten, Clinical Senior Lecturer and Honorary Consultant Haematologist King’s College London.

3 July 2022 Sunday, chair Dr R Walewska, Consultant Haematologist, University Hospitals Dorset, UK CLL Forum Chair.

• CLL relapsed therapy – choices and considerations, Dr Helen Marr, Consultant Haematologist, Northern Centre for Cancer Care, Freeman Hospital, Newcastle.
• Managing complications of standard CLL treatments, Professor Adrian Bloor, Consultant Haematologist and MAHSC Honorary Clinical Chair, University of Manchester, Director of Stem Cell Transplantation, The Christie NHS Foundation Trust.
• CLL and genomics: a new standard? Dr Niamh Appleby, Senior Clinical Researcher in Haematology, Molecular Haematology, John Radcliffe Hospital, Oxford.

For more information, please contact: [email protected]